Applied Therapeutics’ stock surged after the FDA canceled a planned Advisory Committee meeting for govorestat, a treatment ...

UK drugmaker GSK presented positive Phase III trial data at the European Geriatric Medicine Society Congress. The trial ...

Upstream Bio has filed for an IPO on Nasdaq under the symbol "UPB," following recent biotech listings. The company focuses on ...

The EMA's Committee for Human Medicinal Products (CHMP) has elected Bruno Sepodes as its new chair for a three-year term. Sepodes, senior expert at INFARMED, has been with EMA since 2005, holding vari ...

Denmark-based Bavarian Nordic and Gavi, the Vaccine Alliance yesterday announced an advance purchase agreement (APA) to ...

The atopic dermatitis (AD) market is projected to reach $16.7 billion by 2030, according to GlobalData. New therapies like ...

TG Therapeutics yesterday shared new five-year data from the ULTIMATE I & II Phase III trials evaluating Briumvi (ublituximab ...

Daiichi Sankyo’s (TYO: 4568) today revealed that its Vanflyta (quizartinib) has been recommended by the National Institute ...

Merck & Co has announced FDA approval for Keytruda (pembrolizumab) combined with chemotherapy for first-line treatment of ...

Canada’s NanoVation Therapeutics has partnered with Novo Nordisk to advance genetic medicines for cardiometabolic and rare ...

MAIA Biotechnology announced positive interim survival data for its lead candidate, THIO, in a Phase II trial for advanced ...

Women’s health specialist Organon has entered into a definitive agreement to acquire Dermavant Sciences, a Roivant company.